Search research articles
Contact Us
Filters
Showing results (31-40 of 77) with videos related to
Page
of 8
Sort By:
British Journal of Haematology
|
October 22, 2016
Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response
Arash Latifoltojar, Margaret Hall-Craggs, Neil Rabin, et al.
European Journal of Haematology
|
January 9, 2013
Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma
Sally Moore, Sangeeta Atwal, Sajitha Sachchithanantham, et al.
British Journal of Haematology
|
September 9, 2024
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper
Martin Kaiser, Vicky Goh, Simon Stern, et al.
Leukemia & Lymphoma
|
June 24, 2021
Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients
Marquita Camilleri, Thomas McGrath, William Wilson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2024
An Attribution of Value Framework for Combination Treatments
Andrew H Briggs, Alexis Doyle-Connolly, John Schneider, et al.
Haematologica
|
December 5, 2024
Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single-center, real-world experience
Ke Xu, Charles Agbuduwe, Nickolaos Kanellias, et al.
Ejhaem
|
October 17, 2024
Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma
Ke Xu, Eleanor Kaffo, Robert Baker, et al.
British Journal of Haematology
|
May 30, 2019
Long term outcomes in monoclonal gammopathy of renal significance
Akhil Khera, Fotios Panitsas, Faouzi Djebbari, et al.
Leukemia & Lymphoma
|
January 13, 2021
Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set
Monica Ziff, Gabrielle Lawson, Dunnya De-Silva, et al.
Blood Cancer Journal
|
November 7, 2018
Deferred autologous stem cell transplantation in systemic AL amyloidosis
Richa Manwani, Ute Hegenbart, Shameem Mahmood, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 77) with videos related to
Sort By:
Page
of 8
British Journal of Haematology
|
October 22, 2016
Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response
Arash Latifoltojar, Margaret Hall-Craggs, Neil Rabin, et al.
European Journal of Haematology
|
January 9, 2013
Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma
Sally Moore, Sangeeta Atwal, Sajitha Sachchithanantham, et al.
British Journal of Haematology
|
September 9, 2024
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper
Martin Kaiser, Vicky Goh, Simon Stern, et al.
Leukemia & Lymphoma
|
June 24, 2021
Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients
Marquita Camilleri, Thomas McGrath, William Wilson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 31, 2024
An Attribution of Value Framework for Combination Treatments
Andrew H Briggs, Alexis Doyle-Connolly, John Schneider, et al.
Haematologica
|
December 5, 2024
Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single-center, real-world experience
Ke Xu, Charles Agbuduwe, Nickolaos Kanellias, et al.
Ejhaem
|
October 17, 2024
Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma
Ke Xu, Eleanor Kaffo, Robert Baker, et al.
British Journal of Haematology
|
May 30, 2019
Long term outcomes in monoclonal gammopathy of renal significance
Akhil Khera, Fotios Panitsas, Faouzi Djebbari, et al.
Leukemia & Lymphoma
|
January 13, 2021
Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set
Monica Ziff, Gabrielle Lawson, Dunnya De-Silva, et al.
Blood Cancer Journal
|
November 7, 2018
Deferred autologous stem cell transplantation in systemic AL amyloidosis
Richa Manwani, Ute Hegenbart, Shameem Mahmood, et al.
Page
of 8